The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis

被引:321
作者
Stanley, Sarah A. [1 ]
Johndrow, James E. [1 ]
Manzanillo, Paolo [1 ]
Cox, Jeffery S. [1 ]
机构
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA
关键词
D O I
10.4049/jimmunol.178.5.3143
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ESX-1 secretion system is a major determinant of Mycobacterium tuberculosis virulence, although the pathogenic mechanisms 14 resulting from ESX-1-mediated transport remain unclear. By global transcriptional profiling of tissues from mice infected with either wild-type or ESX-1 mutant bacilli, we found that host genes controlled by ESX-1 in vivo are predominantly IFN regulated. ESX-1-mediated secretion is required for the production of host type I IFNs during infection in vivo and in macrophages in vitro. The macrophage signaling pathway leading to the production of type I IFN required the host kinase TANK-binding kinase 1 and occurs independently of TLR signaling. Importantly, the induction of type I IFNs during M. tuberculosis infection is a pathogenic mechanism as mice lacking the type I IFNR were more restrictive for bacterial growth in the spleen than wild-type mice, although growth in the lung was unaffected. We propose that the ESX-1 secretion system secretes effectors into the cytosol of infected macrophages, thereby triggering the type I IFN response for the manipulation of host immunity.
引用
收藏
页码:3143 / 3152
页数:10
相关论文
共 48 条
  • [1] Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes
    Auerbuch, V
    Brockstedt, DG
    Meyer-Morse, N
    O'Riordan, M
    Portnoy, DA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) : 527 - 533
  • [2] Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG
    Bouchonnet, F
    Boechat, N
    Bonay, M
    Hance, AJ
    [J]. INFECTION AND IMMUNITY, 2002, 70 (06) : 3020 - 3025
  • [3] Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to listeria infection
    Carrero, JA
    Calderon, B
    Unanue, ER
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) : 535 - 540
  • [4] Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses
    Coombes, BK
    Valdez, Y
    Finlay, BB
    [J]. CURRENT BIOLOGY, 2004, 14 (19) : R856 - R867
  • [5] Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung
    Cooper, AM
    Pearl, JE
    Brooks, JV
    Ehlers, S
    Orme, IM
    [J]. INFECTION AND IMMUNITY, 2000, 68 (12) : 6879 - 6882
  • [6] Exploring the metabolic and genetic control of gene expression on a genomic scale
    DeRisi, JL
    Iyer, VR
    Brown, PO
    [J]. SCIENCE, 1997, 278 (5338) : 680 - 686
  • [7] Cluster analysis and display of genome-wide expression patterns
    Eisen, MB
    Spellman, PT
    Brown, PO
    Botstein, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 14863 - 14868
  • [8] NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis
    Ferwerda, Gerben
    Girardin, Stephen E.
    Kullberg, Bart-Jan
    Le Bourhis, Lionel
    de Jong, Dirk J.
    Langenberg, Dennis M. L.
    van Crevel, Reinout
    Adema, Gosse J.
    Ottenhoff, Tom H. M.
    Van der Meer, Jos W. M.
    Netea, Mihai G.
    [J]. PLOS PATHOGENS, 2005, 1 (03) : 279 - 285
  • [9] IKKε and TBK1 are essential components of the IRF3 signaling pathway
    Fitzgerald, KA
    McWhirter, SM
    Faia, KL
    Rowe, DC
    Latz, E
    Golenbock, DT
    Coyle, AJ
    Liao, SM
    Maniatis, T
    [J]. NATURE IMMUNOLOGY, 2003, 4 (05) : 491 - 496
  • [10] AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION
    FLYNN, JL
    CHAN, J
    TRIEBOLD, KJ
    DALTON, DK
    STEWART, TA
    BLOOM, BR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2249 - 2254